BMC Psychiatry states that up to one-third of patients with major depressive disorder become resistant to treatment, otherwise known as treatment-resistant depression. In recent years, psilocybin and...
In a recent announcement, the Simcere Pharmaceutical Group — a global pharmaceutical company with origins in China — revealed that the FDA approved its investigational new drug application...
The United States Food and Drug Administration (FDA) is responsible for regulating everything from cosmetic products to medical devices to prescription drugs. In recent years, the FDA has been under enormous pressure to accelerate its...
According to the Mayo Clinic, IgA nephropathy — sometimes referred to as Berger’s disease — is an autoimmune disease in which an antibody called immunoglobulin A (IgA) builds up in the kidneys, leading to local...
Milestone Pharmaceuticals recently announced positive test results from a phase III clinical trial of etripamil, a calcium channel blocker to treat paroxysmal supraventricular tachycardia (PSVT). PSVT...
Months after announcing the development of a nasal epinephrine rescue medication, Orexo Pharmaceuticals announced positive phase I clinical trial data on the drug — called OX640. Epinephrine is a...
Although the development of antibiotics was a significant revolution in medicine, antibiotic education has become increasingly important as the rates of antibiotic-resistant bacteria have risen. As a result, providers are encouraged to...
As the rate of chronic disease in the United States continues to rise, industry members are looking for new and effective methods to manage and treat these disorders. The Pharmaceutical Research and...
In a recent press release, Santen announced that the FDA approved OMLONTI, the company’s newest ophthalmic medication. This ophthalmic solution is composed of 0.002% omidenepag isopropyl. This...
The National Institute of Neurological Disorders and Stroke, a subset of the NIH, estimates that nearly one million people in the United States have Parkinson’s disease. Considering the ever-aging population and the increased risk of...
It’s no secret that drug costs in the United States have continued to increase in the past few years. The Kaiser Family Foundation states that between 2019 and 2022, 48% of prescription drugs had...
Yesterday, the FDA approved Relyvrio, an ALS drug developed by Amylyx Pharmaceuticals, after extensive discussions about the safety and efficacy of the drug. The drug was initially rejected by an FDA...
The United Network for Organ Sharing (UNOS) states that, as of July 2022, there have been 24,414 organ transplants this year in the United States alone. Considering the limitations on the number of organs available for transplant and the...
The FDA approval process is multi-faceted and involves several aspects. One of these aspects is accelerated approval, which is meant to approve drugs to treat severe or fatal diseases. According to a...
Throughout the COVID-19 pandemic, researchers and clinicians have worked tirelessly to develop new antiviral therapies to prevent, treat, and minimize the effects of the SARS-CoV-2 viral infection....
In a recent article published in Nature Medicine, researchers shared information on new biomarkers to develop HIV prevention tools. This publication highlighted research from the Antibody Mediated Prevention (AMP) trials. It is thought...
A retrospective cohort study was conducted using data from January 1, 2004, to December 31, 2018. The researchers reviewed information from the FDA and the European Medicines Agency (EMA) to determine...
The FDA’s Report on The State of Pharmaceutical Quality is published annually to analyze quality measures related to drug manufacturers and products. The report looked at manufacturing site...
On August 19, 2022, the FDA approved AUVELITY — an oral medication manufactured by Axsome Therapeutics — for the treatment of major depressive disorder (MDD) in adults. This medication...
On August 17, 2022, the FDA approved bluebird bio's Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy to treat patients with beta thalassemia who need regular red blood...
